Background & Aims Accurate estimates for the contemporary burden of chronic liver disease
(CLD) are vital for setting clinical, research, and policy priorities. We aimed to review the …

Background & Aims Cirrhosis and hepatocellular carcinoma (HCC) are predicted to increase
in the United States but the accuracy of prior forecasts and the contributions from various …

Disease burden is an important indicator of the state of health of a population. It can be
measured as the frequency (eg, incidence and prevalence) of a condition or its effects …

Cirrhosis is a leading cause of mortality and morbidity across the world. It is the 11th leading
cause of death and 15th leading cause of morbidity, accounting for 2.2% of deaths and 1.5 …

Cirrhosis causes a heavy global burden. In this review, we summarized up-to-date
epidemiological features of cirrhosis and its complications. Recent epidemiological studies …

Background & Aims Chronic liver diseases (CLDs) are major causes of morbidity and
mortality worldwide. We assessed changes in the prevalence of different types of CLD in the …

Cirrhosis is an important cause of morbidity and mortality in people with chronic liver
disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to …

Importance One factor associated with the rapidly increasing clinical and economic burden
of chronic liver disease (CLD) is inpatient health care utilization. Objective To understand …

Background and aims Hepatocellular carcinoma (HCC) risk is high in cirrhosis. We sought to
describe differences in HCC risk, predictors and trends over time according to etiology of …

Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due
to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular …